drugset / Trial / NCT03774706
Sublingual Misoprostol With or Without Intravenous Tranexamic Acid During Hemorrhagic Cesarean Section
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Purpose to evaluates the effects of sublingual misoprostol with or without intravenous tranexamic acid (TA) on reducing post-partum hemorrhage during and after hemorrhagic cesarean section.
Timeline
- Start
- 2019-01-01
- Primary completion
- 2021-12-30
- Completion
- 2022-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tranexamic Acid | Small molecule | 2 g | Intravenous |
| Comparator | Misoprostol | Other / unclassified | 400 ug | Other |
Indications
No indication recorded.